Milestone Pharmaceuticals Inc (MIST)

Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	33.25% 3.639	5.452	6.721	8.622	10.26
Interest Income/Expense	1.75% 0.872	0.857	0.841	0.82	0.036
Operating Income/Loss	24.09% -10.48	-13.80	-15.36	-16.44	-15.50
Income/Loss From Continuing Operations Before Tax	23.93% -10.35	-13.61	-15.08	-16.04	-14.95
Income/Loss From Continuing Operations After Tax	23.93% -10.35	-13.61	-15.08	-16.04	-14.95
Net Income/Loss	23.93% -10.35	-13.61	-15.08	-16.04	-14.95
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Earnings Per Share	34.37% -0.21	-0.32	-0.35	-0.37	-0.35
Diluted Earnings Per Share	34.37% -0.21	-0.32	-0.35	-0.37	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-